Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Link Technologies Invited to Serve as Panellist at TIDES 2012

Published: Wednesday, April 18, 2012
Last Updated: Wednesday, April 18, 2012
Bookmark and Share
TIDES organizers recognize Link Technologies’ expertise in the diagnostic applications of nucleotides.

Link Technologies Ltd has announced that the company’s Technical Manager, Dr Catherine McKeen, has been invited as a panellist at this year’s TIDES conference in Las Vegas (20-23 May).

Dr McKeen will share her expertise during a discussion session entitled ‘The Oligo Supply Chain for Diagnostics - Getting your Research to the Market’, taking place on Wednesday, May 23rd at 11:30 am.

The morning’s discussion session will form part of the IBC’s 8th International ‘Applications of Nucleic Acids Technologies for Molecular Diagnostics’ program, being held concurrently with the TIDES Oligonucleotide and Peptide Research, Technology and Product Development Conference.

Working at the cutting edge of nucleotide chemistry, Link Technologies’ research and development team includes highly qualified chemists and application specialists, whose work involves expanding the range of research and medical applications offered by oligonucleotides.

The company’s extensive product catalogue includes reagents for DNA, RNA, PNA & UNA synthesis and modification, while Link also offers fully bespoke custom synthesis and contract manufacturing services.

Many of Link’s products are specifically aimed at the diagnostics market. These include biotin and ferrocene products, as well as a number of fluorophores, quenchers and linkers.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LINK Strengthens Presence in Switzerland
Link Technologies appoints Swiss company as first partner in Europe.
Tuesday, September 08, 2015
LINK Strengthens Presence in Switzerland with Distribution Agreement
Link Technologies appoints Swiss company Chemie Brunschwig AG as first partner in Europe.
Friday, September 04, 2015
LINK Strengthens Presence in Japan with New Distribution Agreements
Link Technologies appoints Cosmo Bio and Shigematsu to work alongside Gene Design.
Tuesday, June 30, 2015
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos